{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2026-01-26T12:28:39.741152+00:00",
  "news": [
    {
      "title": "Q3 Rundown: Amgen (NASDAQ:AMGN) Vs Other Therapeutics Stocks - Finviz",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQOGNyWVRraWtWeWZpOGpGSjVzQlpnMDMxUjFyRGJzdzV1a3ZBei1sTHBITng5Mm54S055YXYtOER1NDFFU1NPRmZZMkhQSmRRbjZWSUxib244MmhrdWRCdnFVdlc5TGZlLVJteGg1VGhpZ0ZycWNIcmdQY3VTRXJWbFN4VkJCYUIwVUZBbXpBb2ZjZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxQOGNyWVRraWtWeWZpOGpGSjVzQlpnMDMxUjFyRGJzdzV1a3ZBei1sTHBITng5Mm54S055YXYtOER1NDFFU1NPRmZZMkhQSmRRbjZWSUxib244MmhrdWRCdnFVdlc5TGZlLVJteGg1VGhpZ0ZycWNIcmdQY3VTRXJWbFN4VkJCYUIwVUZBbXpBb2ZjZw?oc=5\" target=\"_blank\">Q3 Rundown: Amgen (NASDAQ:AMGN) Vs Other Therapeutics Stocks</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Finviz</font>",
      "published": "2026-01-26T11:55:01+00:00",
      "source": "Finviz"
    },
    {
      "title": "Mutual of America Capital Management LLC Sells 3,290 Shares of Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxNTEJ6ZVEzYkVEMWh6Wm1fTVlNRWc2RTBQU2w1MFN5MWltWV9Dem1hX2FTaVVhbWVjTmkyYlRRajdqVzN0Ni1mLTVVZ09sYVRDampXTVlNWXdWN0tKbE56SVZIUTF6eGhRUFFkcWU5VWNBRE1hU252VWFHTXFxa0doR2pMOUUzTHAxMkdqZ08tVnNWSmIwWlo2LTg3a1NpSUpDQkttLUhoUXlEaHhHSDJ5cHB1Skdkc0R0NHVyekdwcGNIVlNEbEFuaWJ3clhZYVNmN1Rj?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNTEJ6ZVEzYkVEMWh6Wm1fTVlNRWc2RTBQU2w1MFN5MWltWV9Dem1hX2FTaVVhbWVjTmkyYlRRajdqVzN0Ni1mLTVVZ09sYVRDampXTVlNWXdWN0tKbE56SVZIUTF6eGhRUFFkcWU5VWNBRE1hU252VWFHTXFxa0doR2pMOUUzTHAxMkdqZ08tVnNWSmIwWlo2LTg3a1NpSUpDQkttLUhoUXlEaHhHSDJ5cHB1Skdkc0R0NHVyekdwcGNIVlNEbEFuaWJ3clhZYVNmN1Rj?oc=5\" target=\"_blank\">Mutual of America Capital Management LLC Sells 3,290 Shares of Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2026-01-26T12:19:46+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE - Amgen",
      "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPcjU3YXZwYlBDc1k5dHdCcnJnMlhoeC16WlZyTWQzdWpfS1JiMWlsU3kwTjVGVDgyTXlma1l1d0ZrdUF0dnVYcFBpMjhoUUlLVjRDZjZIMFV6SFN4MEgzSVJVUlZFQjRPUENkcnB3cWlfeEEwWUtFSk5hVWU5bUFLZlVmamVLYmRNWUJOV2xZYTZFOV9FVGU0NHJRTVB4VjYxWktSZXhJSDRjZjM1MEpHekxqbXpPU1FpS0p3dXItZm4?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPcjU3YXZwYlBDc1k5dHdCcnJnMlhoeC16WlZyTWQzdWpfS1JiMWlsU3kwTjVGVDgyTXlma1l1d0ZrdUF0dnVYcFBpMjhoUUlLVjRDZjZIMFV6SFN4MEgzSVJVUlZFQjRPUENkcnB3cWlfeEEwWUtFSk5hVWU5bUFLZlVmamVLYmRNWUJOV2xZYTZFOV9FVGU0NHJRTVB4VjYxWktSZXhJSDRjZjM1MEpHekxqbXpPU1FpS0p3dXItZm4?oc=5\" target=\"_blank\">AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2026-01-12T08:00:00+00:00",
      "source": "Amgen"
    },
    {
      "title": "Will 340B Lawsuit Over Drug Discounts Shift Amgen's (AMGN) Access Strategy And Investment Narrative? - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Will 340B Lawsuit Over Drug Discounts Shift Amgen's (AMGN) Access Strategy And Investment Narrative?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2026-01-25T21:16:09+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Amgen CEO says weight loss drug can address 'patient persistence issue' - CNBC",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPZDVWNlNKbjZQcl9NZ2tSSTNyUExnUGFEbXF4d0EwX0Jsczg2WnVhbkNBcGVyTHVGNG5pWTY0ZmdaSGpVem00NDU5VXlIdWhKaEVUZ0REQkMwLVhaTlJNMThtbzdvYjBiRWxrTFR0UE5VbXZ1SDZrdXBlX0VsNE0wVDNNWU8yTjhWbGJ0SV95b21lU0hUSWhHQ0ZweG92aHpsWGZF0gGoAUFVX3lxTE9aT0Mtb29TUlNiZXZ5YldLZFJKS2J0SzJ5dmtjM3BwMzBaclI4SnJkbk1uZFpKX19PWnpHTG54UmZMbjQtSU1BblRKQUNRNUFXWGtRSGI2U2xzNERkOERuSWx2UVlraTE3Z185c1ZXUGtyZF9wNGVwdzE2Qm5FbnhZOVhMQ2ltR0VIM3N2WFFjVTlhM1hod0duX2N0aE9NdU1SZE1rMFlGcg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxPZDVWNlNKbjZQcl9NZ2tSSTNyUExnUGFEbXF4d0EwX0Jsczg2WnVhbkNBcGVyTHVGNG5pWTY0ZmdaSGpVem00NDU5VXlIdWhKaEVUZ0REQkMwLVhaTlJNMThtbzdvYjBiRWxrTFR0UE5VbXZ1SDZrdXBlX0VsNE0wVDNNWU8yTjhWbGJ0SV95b21lU0hUSWhHQ0ZweG92aHpsWGZF0gGoAUFVX3lxTE9aT0Mtb29TUlNiZXZ5YldLZFJKS2J0SzJ5dmtjM3BwMzBaclI4SnJkbk1uZFpKX19PWnpHTG54UmZMbjQtSU1BblRKQUNRNUFXWGtRSGI2U2xzNERkOERuSWx2UVlraTE3Z185c1ZXUGtyZF9wNGVwdzE2Qm5FbnhZOVhMQ2ltR0VIM3N2WFFjVTlhM1hod0duX2N0aE9NdU1SZE1rMFlGcg?oc=5\" target=\"_blank\">Amgen CEO says weight loss drug can address 'patient persistence issue'</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2026-01-13T08:00:00+00:00",
      "source": "CNBC"
    },
    {
      "title": "Ro partners with Amgen to study barriers to obesity care, GLP-1 access - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUEpDQ2FuOHRlZDhZZ3ZoRUM0ejJlTktVSm1QN3J3RE02N0s2ZUZyeFBmekNyalJ2OUhhOW53MFNqWkJCLTBvTllSR0N0WTBadlNLUTNyenAya29nR0dVVE5kU3VRcWpoRktaNFJuWjh2Tm5TWTJVSXpVTTZ2NDZwQWFfZF9iUVFRNm9zSC1LSDdySEtiZzR6bUF5ZlYtSEloYTVjUzZ4V3U0TTU2TmEtX0YxR3MyS0hfT2FCaERSUlk0M1JjQW0xd0I1OTBqcWFENXhKM0hn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUEpDQ2FuOHRlZDhZZ3ZoRUM0ejJlTktVSm1QN3J3RE02N0s2ZUZyeFBmekNyalJ2OUhhOW53MFNqWkJCLTBvTllSR0N0WTBadlNLUTNyenAya29nR0dVVE5kU3VRcWpoRktaNFJuWjh2Tm5TWTJVSXpVTTZ2NDZwQWFfZF9iUVFRNm9zSC1LSDdySEtiZzR6bUF5ZlYtSEloYTVjUzZ4V3U0TTU2TmEtX0YxR3MyS0hfT2FCaERSUlk0M1JjQW0xd0I1OTBqcWFENXhKM0hn?oc=5\" target=\"_blank\">Ro partners with Amgen to study barriers to obesity care, GLP-1 access</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2026-01-13T08:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "Sagebrush sues Amgen over 340B program row - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxOV3FNclBBVmlyd3pVVnM4UkYxT3pSNDJnT012RDBBRnczQ2hrR0YwalZRa1FpUlBSUF91NmVEQWthd3NURi1CM0VubHFiLTNyRzhSdjhpaktoNnZrY0xFazBhSDRBV3BnVTU5RUpudW9BbENCeTc5Zkt1Y1U5aWVLRHhxMjVuSVE5MEtFZ3k3REg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxOV3FNclBBVmlyd3pVVnM4UkYxT3pSNDJnT012RDBBRnczQ2hrR0YwalZRa1FpUlBSUF91NmVEQWthd3NURi1CM0VubHFiLTNyRzhSdjhpaktoNnZrY0xFazBhSDRBV3BnVTU5RUpudW9BbENCeTc5Zkt1Y1U5aWVLRHhxMjVuSVE5MEtFZ3k3REg?oc=5\" target=\"_blank\">Sagebrush sues Amgen over 340B program row</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2026-01-22T13:25:23+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "Amgen (AMGN) Faces 340B Lawsuit: What Does Sagebrush Dispute Reveal About Its Stakeholder Strategy? - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOUDdVRGpzZWhQMjNDRWs5Szdob0pIMDdveUNiNTg5RlFnQ0ZJNGJmRUJUUkVsUGlIanhSNF9GcmdfNXhEOEJWN0hxa3RfQkRkVVAyS3p4b1poS0s1NjZQSmJQNVhlbGc4aHYtWFA3a3A0aXZFb29BWEtOb0V5dHVYYQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigAFBVV95cUxOUDdVRGpzZWhQMjNDRWs5Szdob0pIMDdveUNiNTg5RlFnQ0ZJNGJmRUJUUkVsUGlIanhSNF9GcmdfNXhEOEJWN0hxa3RfQkRkVVAyS3p4b1poS0s1NjZQSmJQNVhlbGc4aHYtWFA3a3A0aXZFb29BWEtOb0V5dHVYYQ?oc=5\" target=\"_blank\">Amgen (AMGN) Faces 340B Lawsuit: What Does Sagebrush Dispute Reveal About Its Stakeholder Strategy?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-01-22T23:11:30+00:00",
      "source": "Yahoo Finance"
    }
  ],
  "product_launches": [
    {
      "title": "AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S. - Amgen",
      "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPaE9rZlFxUjZZSGd5Yk85X1ZoVGtfQ0NTYW9jV1pQLVNfbU5tUmV2NGRFdnZpaUNoLTFCV2RxNEgzTmUxdS11OHpWczc2ZDFhblp3WjB2dzZ0el9JQjgwMWFDc3dpTU5LTk5yeHZEaExDVVUwb2JBR1RDZHNTTUpaWXhFWnR6M3V5VlVhb3dENHh4LVpRMDlrNFZrWkdnOWlXTGt6cEozc1JKeEg1OW5WOWZBMjB6SFd6eFRmSTBSMl8xbmJXX0pyWk1GMllyeUZiX1E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0gFBVV95cUxPaE9rZlFxUjZZSGd5Yk85X1ZoVGtfQ0NTYW9jV1pQLVNfbU5tUmV2NGRFdnZpaUNoLTFCV2RxNEgzTmUxdS11OHpWczc2ZDFhblp3WjB2dzZ0el9JQjgwMWFDc3dpTU5LTk5yeHZEaExDVVUwb2JBR1RDZHNTTUpaWXhFWnR6M3V5VlVhb3dENHh4LVpRMDlrNFZrWkdnOWlXTGt6cEozc1JKeEg1OW5WOWZBMjB6SFd6eFRmSTBSMl8xbmJXX0pyWk1GMllyeUZiX1E?oc=5\" target=\"_blank\">AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "Amgen"
    },
    {
      "title": "A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMigwFBVV95cUxPdXV6ZkFTSE1jV2hDZ0I2VlJTRDZvT1Z5T0toZUswZUE1WHk1YVI4dnNncUpBY3BDX0JJejBvdFB3VGx6ejNhaENaeVMtcE9Mc1diWUFIQXZtNVFyT1VId2FIQ2xSMHpyLVk1T0ljbmVCMnR2cXZjVXVIZDNMeHgwUTBVYw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxPdXV6ZkFTSE1jV2hDZ0I2VlJTRDZvT1Z5T0toZUswZUE1WHk1YVI4dnNncUpBY3BDX0JJejBvdFB3VGx6ejNhaENaeVMtcE9Mc1diWUFIQXZtNVFyT1VId2FIQ2xSMHpyLVk1T0ljbmVCMnR2cXZjVXVIZDNMeHgwUTBVYw?oc=5\" target=\"_blank\">A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-02T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - Pharma Voice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharma Voice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "Pharma Voice"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2026-01-23",
      "close": 344.75
    },
    "history": [
      {
        "date": "2026-01-14",
        "close": 328.9700012207031
      },
      {
        "date": "2026-01-15",
        "close": 330.0299987792969
      },
      {
        "date": "2026-01-16",
        "close": 330.4100036621094
      },
      {
        "date": "2026-01-20",
        "close": 331.0
      },
      {
        "date": "2026-01-21",
        "close": 343.6000061035156
      },
      {
        "date": "2026-01-22",
        "close": 347.07000732421875
      },
      {
        "date": "2026-01-23",
        "close": 344.75
      }
    ],
    "name": "Amgen Inc."
  }
}